Orbit Discovery is a peptide display technology company that identifies peptide drugs for chronic diseases. The Company’s Orbit in vitro display technology uses small beads to link randomized peptide sequences to the DNA which encodes them; and provides screening tools that support the discovery of peptides for a range of disease types. It focuses on establishing a screening platform that identifies peptide drug candidates for internal industry drug discovery programs and via collaborative research.
|Employees (est.) (May 2019)||25||(+9%)|
Orbit Discovery total Funding
Orbit Discovery latest funding size
Time since last funding
|a year ago|
Orbit Discovery investors
|Borealis Ventures, Oxford Technology Management, Oxford Sciences Innovation, Perivoli Innovations, RT Ventures, Oxford University|
When was Orbit Discovery founded?
Orbit Discovery was founded in 2015.
Who are Orbit Discovery key executives?
Orbit Discovery's key executives are Alex Batchelor, Terry Rabbitts and Graham Ogg.
How many employees does Orbit Discovery have?
Orbit Discovery has 25 employees.
Who are Orbit Discovery competitors?
Competitors of Orbit Discovery include CerSci Therapeutics, BioPorto and Unilabs.
Where is Orbit Discovery headquarters?
Orbit Discovery headquarters is located at Brookes Innovation Hub, Gipsy Lane, Oxford.
Where are Orbit Discovery offices?
Orbit Discovery has an office in Oxford.
How many offices does Orbit Discovery have?
Orbit Discovery has 1 office.